Perfromance Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Perfromance Wealth Partners's AMGN Position: Q2 2026 in Review
Perfromance Wealth Partners reduced its Amgen (AMGN) stake by 0.8% in Q2 2026, selling an estimated $8.22K and leaving 2,979 shares worth $1.08M. The position accounts for 0.03% of the portfolio, ranked #94.
Perfromance Wealth Partners first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.61M in Q4 2023. 3,148 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Perfromance Wealth Partners held 2,979 shares of Amgen worth $1.08M as of Q2 2026.
- Perfromance Wealth Partners sold 24 Amgen shares in Q2 2026, an estimated $8.22K.
- Amgen made up 0.03% of Perfromance Wealth Partners's portfolio in Q2 2026, its #94 holding.
- Perfromance Wealth Partners first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Perfromance Wealth Partners's Amgen position peaked at $8.61M in Q4 2023.
- 3,148 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Perfromance Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.